| BD (n = 38) | BPD (n = 25) | HC (n = 43) | Test statistic | P | Post-hoc |
---|---|---|---|---|---|---|
Gender | ||||||
 Female n (%) | 24 (63.2) | 22 (88) | 29 (67.4) | χ2 = 4.881 | 0.087 | – |
Age, year ± SD | 39.0 ± 13.1 | 34.1 ± 11.2 | 39.84 ± 12.9 | F = 1.794 | 0.171 | – |
BMI, kg/m2 ± SD | 26.8 ± 4.1 | 27.4 ± 6.3 | 24.5 ± 4.3 | F = 3.657 | 0.029 | n.s |
Smoker, n (%) | 7 (21.9) | 7 (30.4)) | 2 (5) | χ2 = 7.818 | 0.022 | BD > HC BPD > HC |
Drinks Alcohol, n (%) | 28 (77.8) | 14 (58.3) | 31 (72) | χ2 = 2.691 | 0.260 | – |
Questionnaire assessment | ||||||
 QIDS, mdn ± IQR | 5.5 ± 6.5 | 12 ± 12.5 | 2 ± 1.5 | χ2 = 50.586 |  < 0.001 | BD > HC BPD > HC BPD > BD |
 ASRM, mdn ± IQR | 1 ± 2 | 1 ± 3.5 | 0 ± 0 | χ2 = 11.663 |  < 0.003 | BD > HC BPD > HC |
Mood Zoom Items | ||||||
 anx RMSSD ± IQR | 0.87 ± 0.54 | 1.39 ± 0.58 | 0.55 ± 0.65 | χ2 = 42.81 | < 0.001 | BD > HC BPD > HC BPD > BD |
 sad RMSSD ± IQR | 0.72 ± 0.71 | 1.40 ± 0.43 | 0.31 ± 0.75 | χ2 = 41.662 |  < 0.001 | BD > HC BPD > HC BPD > BD |
 elt RMSSD ± IQR | 0.67 ± 0.73 | 1.14 ± 1.06 | 0.67 ± 0.88 | χ2 = 10.489 | 0.005 | BPD > HC |
 enr RMSSD ± IQR | 0.93 ± 0.70 | 1.22 ± 0.90 | 0.79 ± 0.51 | χ2 = 11.558 | 0.003 | BPD > HC BPD > BD |
 ang RMSSD ± IQR | 0.71 ± 0.58 | 1.24 ± 0.97 | 0.31 ± 0.49 | χ2 = 36.695 |  < 0.001 | BD > HC BPD > HC BPD > BD |
 irr RMSSD ± IQR | 0.91 ± 0.71 | 1.53 ± 1.05 | 0.48 ± 0.78 | χ2 = 39.167 |  < 0.001 | BD > HC BPD > HC BPD > BD |
Medication | ||||||
 Using psychotropic medication, n (%) | 36 (94.7) | 19 (87.3) | – | χ2 = 4.775 | 0.029 | – |
 Lithium | 16 (42.1) | 0 (0) | – | χ2 = 14.11 |  < 0.001 | – |
 Anticonvulsant | 15 (39.5) | 1 (4) | – | χ2 = 10.015 | 0.002 | – |
 Antipsychotic | 25 (65.8) | 5 (20) | – | χ2 = 12.675 |  < 0.001 | – |
 Antidepressant | 13 (34.2) | 19 (76) | – | χ2 = 10.536 | 0.001 | – |
 Hypnotic | 3 (7.9) | 1 (1.5) | – | χ2 = 0.339 | 0.561 | – |
 Anxiolytic | 1 (2.6) | 6 (24) | – | χ2 = 6.971 | 0.008 | – |